Drug
TD 5108
TD 5108: highest development phase Phase 2, developed by Theravance Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Theravance Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-5108 NCT00391820 | Phase 2 | Chronic Constipation |
Latest
No recent events.
Follow TD 5108 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.